Poster
8

Development of screening in CD4+ T cells to identify drug targets for immune-mediated inflammatory diseases

Authors

G Bergamin1; R M Trigg1; L L Brayshaw1; B E Saunders1; R I Jepras1; L Suckling1; M New1; R Kasprowicz1; W Li1; K Tvermosegaard1; D Tough1; R A Randle1; H D Lewis1; K Maratou1
1 GSK, UK

Abstract

Immune-mediated inflammatory diseases (IMIDs) are a group of disorders characterised by tissue inflammation as a result of dysregulated immune responses. Enhancing the production of anti-inflammatory cytokines from T cells may balance the inflammatory state of IMIDs and provide therapeutic benefit. To this end, we developed a genome-wide CRISPR screen in primary CD4+ T cells to identify genes which, when knocked out, lead to increased release of an anti-inflammatory cytokine. We extensively optimised several elements of the screening workflow including lentiviral transduction, lentivirus production, Cas9 electroporation in bulk cell populations and FACS sorting, and ran a focused screen based on a mini library of ~1,000 gRNAs to assess the performance of the workflow before conducting a genome-wide screen.


Hosted By

ELRIG
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Login
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021